Affymetrix, Inc.

Industry

  • Biotechnology
    • Nanotechnology, Chips, etc.
    • Drug Discovery Technologies
      • Bioinformatics
      • Genomics-Proteomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals

Other Names/Subsidiaries

  • eBioscience Holding Company
  • Eureka Genomics
  • Neomorphic
See more in Biomedtracker

Latest on Affymetrix, Inc.

Scrip

Appointments: G1 Therapeutics, Breath Therapeutics, Fortress Biotech, Freeline Therapeutics, Enterome and Symic Bio

 
• By Lubna Ahmed

GlaxoSmithKline PLC 's former CEO, Sir Andrew Witty , has been appointed to G1 Therapeutics Inc. 's board of directors. Witty is chancellor of the University of Nottingham and retired from GSK

Medtech Insight

M&A Analysis: Underwhelming 2016, But Hope For 2017 US Market Boom

 
• By Catherine Longworth

A final flurry of activity in December rounded off 2016 with a tally of 174 medtech M&A deals, a year-on-year decline from the 237 deals tracked by Medtech Insight in 2015 and 269 in 2014. But while

Scrip

APPOINTMENTS: Apellis, Araim, Ascendis, Chronos, Intrexon and Proteostasis

 
• By Scrip Team

Chrono Therapeutics Inc. , a private biotech company focused on ageing diseases, brain and nervous system disorders, has named Drs. Fraser Murray and Timothy Schulz-Utermoehl vice presidents

Medtech Insight

Legal News In Brief

 
• By Elizabeth Orr

Illumina To Pay $21m To Enzo In Patent Case Illumina Inc. has agreed to pay $21m to Enzo Life Sciences Inc. to settle a patent infringement case pending in Delaware Federal District Court. Enz